William Blair upgraded Elanco (ELAN) to Outperform from Market Perform after hosting investor meetings with management. The conversations gave the firm more color around Elanco’s current momentum and pipeline efforts that give it confidence to upgrade the shares. The core business has stabilized from improved execution, which provides a “better floor” for innovation products, the analyst tells investors in a research note. In the near term, Blair believes Elanco’s innovation products can help accelerate growth. Long term, the company has a pipeline, backed by acquisitions and relatively new management appointees, that can deliver additional catalysts for growth over the next few years, contends the firm.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco upgraded to Outperform from Market Perform at William Blair
- Elanco Animal Health: Balanced Growth Prospects Amid Competitive Challenges and Innovation Uncertainties
- Zoetis downgraded to Hold from Buy at Stifel
- Elanco’s Zenrelia granted positive opinion by EU veterinary product committee
- Elanco Animal Health: Hold Rating Amid Strategic Shifts and Awaited Clarity on Key Initiatives